Search for: "Health Consultants Inc." Results 1201 - 1220 of 4,014
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Jun 2022, 6:33 am
The SEC’s Cyber Disclosures Posted by Shiva Rajgopal (Columbia University) and Alex Sharpe (Sharpe Consulting LLC), on Friday, June 3, 2022 Tags: Cybersecurity, Ransomware, Risk, Risk disclosure, SEC, SEC rulemaking, Securities regulation CEO Pay Proposals Face Growing Investor Disapproval Posted by Subodh Mishra, Institutional Shareholder Services, Inc., on Friday, June 3, 2022 Tags: Executive… [read post]
7 Mar 2023, 9:01 am by Cynthia Marcotte Stamer
  Solutions Law Press, Inc. invites you receive future updates by registering on our Solutions Law Press, Inc. [read post]
10 Oct 2007, 9:15 pm
Fentora, a cancer pain medication, is too frequently misused and improperly prescribed, according to a Public Health Advisory recently issued by the U.S. [read post]
5 May 2020, 1:37 pm by Michael Cannan
If you take Belviq, stop immediately and consult your doctor. [read post]
18 Feb 2019, 7:27 am by Ben Vernia
*   *   * The settlement announced today resolves allegations that the company violated the Anti-Kickback Statute and the Stark Law by providing to referring physicians subsidies for electronic health records (EHR) systems and free or discounted technology consulting services. [read post]
14 Mar 2013, 11:00 am by Marvin Kirsner
See Advanced Services Inc., Case No. 26-CA-63184 (July 2, 2012). [read post]
2 Apr 2018, 4:03 pm by Kevin LaCroix
In the following guest post, David Fontaine, CEO of Kroll, Inc. and its parent, Corporate Risk Holdings, and John Reed Stark, President of John Reed Stark Consulting and former Chief of the SEC’s Office of Internet Enforcement, take a look at the SEC’s guidance, with a particular focus on what the agency’s statement has to say about the duties of corporate directors. [read post]
8 Apr 2015, 5:31 am by Mary Jane Wilmoth
  Denham is a patient safety consultant who operates the consulting company Health Care Concepts Inc. and the research organization Texas Medical Institute of Technology, both of which are also parties to the settlement. [read post]
28 May 2013, 12:24 am by Ben Vernia
On May 24, the Department of Justice announced that ISTA Pharmaceuticals, Inc. had entered a guilty plea and agreed to pay a combined civil and criminal settlement of $33.5 million to resolve claims brought in two qui tam suits that the company promoted one of its opthalmological drugs off-label. [read post]